awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40061894-9A00F41E-5FC9-4399-9599-CBE8747DC18F
Q40061894-9A00F41E-5FC9-4399-9599-CBE8747DC18F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40061894-9A00F41E-5FC9-4399-9599-CBE8747DC18F
The role of natalizumab in the treatment of multiple sclerosis: benefits and risks.
P2860
Q40061894-9A00F41E-5FC9-4399-9599-CBE8747DC18F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40061894-9A00F41E-5FC9-4399-9599-CBE8747DC18F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
027090c0ba2ab0852da7606cea64e4e604fa861d
P2860
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.